Benzinga's Top Upgrades, Downgrades For October 16, 2018

Top Upgrades

  • BMO Capital upgraded Marvell Technology Group Ltd. MRVL from Market Perform to Outperform. Marvell Technology shares rose 1.55 percent to $18.40 in pre-market trading.
  • HSBC upgraded Las Vegas Sands Corp. LVS from Hold to Buy. Las Vegas Sands shares rose 0.5 percent to $56.10 in pre-market trading.
  • Morgan Stanley upgraded Government Properties Income Trust GOV from Underweight to Equal-Weight. Government Properties Income Trust shares rose 1.8 percent to $10.00 in pre-market trading.
  • B. Riley upgraded Arbutus Biopharma Corp ABUS from Neutral to Buy. Arbutus Biopharma shares fell 3.94 percent to close at $4.14 on Monday.

 

Top Downgrades

  • KeyBanc downgraded Integrated Device Technology Inc IDTI from Overweight to Sector Weight. Integrated Device Tech shares fell 0.41 percent to $46.57 in pre-market trading.
  • Jefferies downgraded Pinnacle Foods Inc PF from Buy to Hold. Pinnacle Foods shares dropped 0.42 percent to $65.85 in pre-market trading.
  • Stifel Nicolaus downgraded Antero Midstream Partners LP AM from Buy to Hold. Antero Midstream Partners shares fell 0.21 percent to $32.65 in pre-market trading.
  • Bank of America downgraded Spero Therapeutics Inc SPRO from Neutral to Underperform. Spero Therapeutics shares rose 1.67 percent to close at $9.76 on Monday.
  • SunTrust Robinson Humphrey downgraded Amneal Pharmaceuticals Inc AMRX from Buy to Hold. Amneal Pharmaceuticals shares fell 1.8 percent to $18.40 in pre-market trading.

 

Top Initiations

  • Barclays initiated coverage on Stryker Corporation SYK with an Overweight rating. The price target for Stryker is set to $198. Stryker shares closed at $169.41 on Monday.
  • Benchmark initiated coverage on Tilray Inc TLRY with a Buy rating. The price target for Tilray is set to $200. Tilray shares closed at $165.64 on Monday.
  • Analysts at Bank Of America initiated coverage on Y-mAbs Therapeutics, Inc CAMP with a Buy rating. The price target for Y-mAbs Therapeutics is set to $26. Y-mAbs Therapeutics shares closed at $21.60 on Monday.
  • Analysts at Bernstein initiated coverage on Philip Morris International Inc. PM with an Outperform rating. The price target for Philip Morris is set to $97. Philip Morris shares closed at $83.49 on Monday.
  • Barclays initiated coverage on Abbott Laboratories ABT with an Overweight rating. The price target for Abbott is set to $80. Abbott shares closed at $68.70 on Monday.
  • Analysts at Bernstein initiated coverage on Altria Group Inc MO with a Market Perform rating. Altria closed at $61.44 on Monday.
  • Citigroup initiated coverage on Independence Realty Trust Inc IRT with a Neutral rating. Independence Realty Trust shares closed at $9.78 on Monday.
  • BTIG Research initiated coverage on Esperion Therapeutics Inc ESPR with a Buy rating. The price target for Esperion Therapeutics is set to $82. Esperion Therapeutics shares closed at $44.94 on Monday.
  • Barclays initiated coverage on Becton Dickinson and Co BDX with an Equal-Weight rating. The price target for Becton Dickinson is set to $278. Becton Dickinson shares closed at $238.31 on Monday.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: UpgradesDowngradesInitiationPre-Market OutlookAnalyst RatingsCasinos & GamingConsumer DiscretionaryInitiationstop upgrades
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!